BioCentury
ARTICLE | Company News

Schering-Plough, Toyama deal

June 28, 2004 7:00 AM UTC

SGP licensed from Toyama exclusive worldwide rights to garenoxacin ( T-3811), a quinolone antibacterial that has completed Phase III testing. SGP's rights exclude China, Japan and Korea. Toyama will r...